GI INNOVATION

gi-innovation-logo

GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovationโ€™s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.

#SimilarOrganizations #People #Website #More

GI INNOVATION

Social Links:

Industry:
Biotechnology

Founded:
2017-01-01

Address:
Seoul, Seoul-t'ukpyolsi, South Korea

Country:
South Korea

Website Url:
http://www.gi-innovation.com

Total Employee:
11+

Status:
Active

Total Funding:
31 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail JsDelivr Cloudflare JS CDN JS


Similar Organizations

accutarbio-logo

AccutarBio

AccutarBio employs artificial intelligence to revolutionize drug discovery.

innovative-cellular-therapeutics-logo

Innovative Cellular Therapeutics

Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.

not_available_image

Qiyu Biotech

Qiyu Biotech is an innovative macromolecular drug developer.

silicon-therapeutics-logo

Silicon Therapeutics

Silicon Therapeutics is a fully integrated drug design, research, and development company.

Current Employees Featured

myoung-ho-jang_image

Myoung Ho Jang
Myoung Ho Jang Founder & Chairman @ GI Innovation
Founder & Chairman

hong-joon-ho_image

Hong Joon-ho
Hong Joon-ho CEO @ GI Innovation
CEO
2021-01-01

Founder


myoung-ho-jang_image

Myoung Ho Jang

Official Site Inspections

http://www.gi-innovation.com Semrush global rank: 3.81 M Semrush visits lastest month: 3.51 K

  • Host name: 58.230.162.200
  • IP address: 58.230.162.200
  • Location: Daegu South Korea
  • Latitude: 35.8723
  • Longitude: 128.5924
  • Timezone: Asia/Seoul
  • Postal: 41934

Loading ...

More informations about "GI Innovation"

GI INNOVATION

2021-GI Innovation CEO. 2020-2021. CEO, AllenCare Corp. 2020-2021. CEO, Interpark Bio-Convergence Corp. 2018-2020. Vice President, Interpark Bio-Convergence CenterSee details»

GI Innovation - Crunchbase Company Profile & Funding

GI Innovation is a global leader of microbiome drug development. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log โ€ฆSee details»

GI INNOVATION - LinkedIn

GI INNOVATION | 647 followers on LinkedIn. GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around ...See details»

GI Innovation 2025 Company Profile: Stock โ€ฆ

GI Innovation Inc is a bio-venture company that researches and develops protein new drugs through well-structured translational research. The primary โ€ฆSee details»

GI Innovation - Products, Competitors, Financials, Employees ...

GI Innovation was founded in 2017. Where is GI Innovation's headquarters? GI Innovation's headquarters is located at 167 Songpa-daero, Songpa-gu, Seoul. What is GI Innovation's โ€ฆSee details»

GI Innovation - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 15, 2021: Series C - GI โ€ฆSee details»

GI Innovation - Company Profile

GI Innovation blogs, articles and journal posts. About Us The Partnership Tree established in 2003 (initially a pharmaceutical company directory) supporting companies in the finding, โ€ฆSee details»

GI Innovation - VentureRadar

GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. ... Vaiomer France Privately โ€ฆSee details»

GI INNOVATION

GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy From the left, Rhee Byung-geon, Chairman and CEO of GI Innovation, Dr. Crystal โ€ฆSee details»

GI Innovation, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore GI Innovation, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 6 news, and 8 literature, Disease Domain:Neoplasms, Endocrinology and Metabolic โ€ฆSee details»

GI INNOVATION

The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and developing a fusion protein using the GI-SMARTโ„ข platform. Currently, research โ€ฆSee details»

Organization: GI Innovation - Cbonds.com

GI Innovation. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»

GI Innovation begins patient enrollment for P1/2 study of 4th-gen ...

Mar 6, 2025 GI Innovation said it would begin patient enrollment for its phase 1/2a clinical trial of GI-108, a fourth-generation metabolic immunotherapy.The company is collaborating with โ€ฆSee details»

GI Innovation secures first KRW 20 billion after listing: focus on ...

Jul 31, 2024 [by Lee, Young Sung] Innovative new drug development company GI Innovation announced on July 30 that it is raising funds for the first time since its listing in March 2023. โ€ฆSee details»

Gi Innovation plans 80 billion won capital increase for clinical trials ...

Dec 20, 2024 The funds raised will be used for the clinical trials of immuno-oncology drugs GI-101A and GI-102 in Korea and the U.S., clinical trials for a large-scale anticancer drug GI-108, โ€ฆSee details»

GI Innovation - Updates, News, Events, Signals & Triggers

GI Innovation may be growing as it is part of the biotechnology industry and has been involved in securing licensing deals. The company is among the 14 Korean drugmakers that have โ€ฆSee details»

GI Innovation, LaNova Medicines sign MOU to develop โ€ฆ

Jan 20, 2025 GI Innovation said it signed a memorandum of understanding (MOU) with LaNova Medicines, a Chinese-based botech, to jointly develop a combination therapy for pancreatic โ€ฆSee details»

GI Innovation to focus on licensing deals at 2025 J.P. Morgan ...

Jan 8, 2025 GI Innovation, a Korean biotech company, announced its participation in the 2025 J.P. Morgan Healthcare Conference from Jan. 13-16 in San Francisco, Calif., U.S.The โ€ฆSee details»

GI Alliance and Iterative Health Partner to Advance GI Clinical ...

2 days ago The organization partners with the nationโ€™s premier GI physician practices, providing operational management, ancillary service development, and patient engagement support. By โ€ฆSee details»

GI Innovation-ๅŠจ่„‰็ฝ‘ - vbdata.cn

Jan 1, 2017 GI Innovation ๆ˜ฏไธ€ๅฎถ็”Ÿ็‰ฉ้ฃŽ้™ฉๆŠ•่ต„ๅ…ฌๅธ๏ผŒ้€š่ฟ‡็ป“ๆž„ๅฎŒๅ–„็š„่ฝฌๅŒ–็ ”็ฉถ๏ผŒ็ ”ๅ‘ๅˆ›ๆ–ฐ็š„่›‹็™ฝ่ดจๆ–ฐ่ฏใ€‚GI Innovation็š„ไธป่ฆ็ ”ๅ‘้ข†ๅŸŸๆ˜ฏๅ…็–ซๆŠ—็™Œๅ‰‚ๅ’Œ่ฟ‡ๆ•ๆฒป็–—ๅ‰‚๏ผŒๅˆฉ็”จGI-SMARTโ„ขๅนณๅฐๅผ€ โ€ฆSee details»

linkstock.net © 2022. All rights reserved